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. High inlracellular concentration "Inaclivated by Ihe low pH ot
b,oneh'al sec,enon
The treallllclll of evere IIIfcca m anJ particularly of
nosocomial mfect'lons should be based on an accurate stratc~:
III the t-jr.;t phasc, cultures should be l11ade m ordcr to target the
anCiblOCI therapy: then, it IS LmpOl'Um to begin an cmpmcal
u1erap , e peclally ah'<llllst Gram-negative bacteria, whi hare
responSible for Ill. ny severe infections. and where dcbyed
thera, y IS rdated to Increased lIlortaltty.
mpmcal thcrapy should consider the following:










• site of IIlfcn;on:
• anallllle'itical alld epldcl\lIological data about probable
eoology;
• ill I1Ilro scnsltivity of pathogens accordlllg w tocal
cplcknuology;
• phann; coklllenc prop,>nics 0 antlbloli , such a tlSSUC
dlstnbutlon
The chOIce ofclIlpmca! antibiotlc therapy mw.r con Ider the
tollow1I1g:
• typl' of nucroorg;JrIIsm:
• me of mfection:
• II st charactcristics.
W llh rqprd to micrClorgamS11l. we lllUSl cOlulder that
anablone resist: nce progressIVely incre:! cs \ ith the usc,
orrl:'lpnnding aUlhor and repnnt rClluem: Dante l3a«cm, linic~
delle M.!;lLUc Inrelri"". I I '. .M.. Ulllver<lca dcgh Snrdi di Genova.
Clloa, h:lI'
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sometimes Irranonal. of thL'S': dnlg'S. P rrlcular problems arc
posed by ~-1JClamJSt' producers. fcnncnnng and nonfermcllt-
illg Gr:tm-negative bactena, mcrllicillin-resist 11\ St, phylococ i
and glycopeptide-reSIstant enteroe cci.
When con. iderin~ u1e site of infection, we mllSI consider
rile f.,cLOrs reporled III Table I. AJ1 example of a physiological
bamer 15 the blood-brondu barner: [he antibIOtic diffUSIon ill
rhe n: plr:ttOry tract is sUllll11:mzed in Table 2,
The choice 0 ntibiotic i also rdated 10 underlying diseases
in the ho. t: inl1l1unoddiciency dm' 10 HIV, c, ncr, chc-
11l0ther:tpy. srcroid~. transplants, bums, evere trauma, organ
f.,ilure, allergy. genctlc factor.;.
AdeLluare empmcal ther:tpy must be early, broad spectrum,
highly di~trihLlted. r:tpidly bactericidal and prolonged.
l3a teri id1.l activity may be imporrant: the III l rapid
bacrericid,l agents are alltinoglycosides and fluoro'luil1olones,
willie f3-bCl:II11 ar' lIlor..: .lowly b"ctenCldal rI].
ptimlZ3tion of empirical therapy for severe infections is a
very dIfficult challenge because of increasing bacterial
Table 3 AmlmlcroblOl resislance: current problems
Table 1 ChOice of empirlcal therapy, factors 'elated to Ihe Slle of
Inf&ctlon
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hype,producing chromosomal Ols
Nonfermenlers producing zinc enzymes
OrganIsms producmg modifYing enzymes
OUlnolone,reslslonl Escher/chm col/.
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Table 4 Antlm,crob,al ws,swnce emorg,ng problems
Table 5 POI nllal problems wllh Ihlrd·genorRilon cephalosporrns
SUbopllfnol activity agarnsl Gram pOSlt'vo organrsms
EmarD nee ot pon,c,lIll1,rOSISlOnt vll,dilns Sltlrp,ococc,
Bush group 1 1l,lactamose-produc,ng baclen (Enloroboc!er, elc)
Bactena prodUCIng ES 1~ls'
Res'slance among nonfe,menters
enzymes
SrenorropllOmonns nJillrophr/w Mull,ple·anllb,o"c·r 5' Ian I
dlssemlnJllon
Blirkholdeflil Cep,1CIiJ MlIll,ple·anllb,ot,c-ws' 'nn,
d,ss mlnallon
BIlClIJfoir/es /ragills New cnrbapenem hydrolyzlflg
enzymes
REFERENCES
IKL1Ill,l'e pro lucer\ and an 111 rt'a trig l1umht'r of nontenm'l1I-
Ill\: ml1lndnl\:-r"~I'tall\ ,r.JI11-nl'g;ltl\'C Slr3m~ with m,llly
pott'llll,ll prohlem' (T,lble 5),
Flllorcl(,I'"lllllom', h;lvI' goo,1 plunll.lCokllletl ,har,I,I,'Il-
tin, "~I','cla1Jy III th<: respIratory tr:ter, and r:tpid bal"lencldaJ
.1Cl1VIlY. bUI Ihelr liS" III lllonorhcr:tpy l~ not ;ldvl~lblt: because
of the mk uf l'lllerl,:l'nCC of re'l>lalll \lJphyloco '('I and E. {"II.
Allllrher allel'l1,IIIV" !t')ICe I 01 1:(('.1 by C:lfh,lpenclIl"
,d[hollgh eXI,'ndnl lII" of lh",,, h,l\ f:lls ...d important
l'pldeIllIOluI'!C,11 ,md I'h,lnll,lCO-ecollullllC ,.,ncem"
Pam ubr allel1{Jon ,!tollid he !'-'1v,'n to fourth-gener,lllon
(cphalo>ponll> III the tre,lllllent of scvcre II1tCCtIOIl\, paro(u-
Lui, Iho><' du,' ro .r.1lll-nq;~t1\'ehaclt'na. IUlieal H'lul~ II 1111
Intl·m"uoll.d tnah hav... I'fl)\'ed rhl' CO·......II\·ent~\ of cdeplIIll' 111
~e\'l'H' IlUIOI: 1111.1 mf':etlom, III lebnlc nemrol'enic I'anelll'\
.I1ld lit Lit1'1 12
In n<:lIrr0I'<'1l\C paucnL, and 111 gellt'ral 111 cvere infectlonl.
I: 'fcl'llll'" pr<:sellls, j1;fc.1t<:r antl- .raln-pOSltlVe Jctl\'lry (I:XCC!"
ag:t111st MItSA) thall do ulha Jllllp>eudomorul 'I:ph lospur-
lit>. ,\ !-Ire,ller el1ic. cy apum ~-l.lCIJIIU\1: ~oul' I ,lid
... xtemled- I'cclrulll ~-bctamJ\l'proJu e~, Jlld ct1ic,Ky .1g.1111"
11I:llly l1011t.mnenting b, tl'rt,t 151.
III 1Il'lIIropetll' I':menti, <'t'lc:plllle Teprc ... nl\ ,I currcl1t1y
:Icccptni "'1II I' II'Ica I tha:lp ,l\rCn1JlIVe [() n:ti;lzHillllC and
pt'lli'llIim plus anunoglycoslde as docullIcmeJ III lllany
tntCn1allonaJ rnaJ.\ 1-1.61.
di:pll11<: d1ica 'y 111 I'rovcn or 5U pc led ICpU 'Clllla I'
C Illparahle With ceftazidillle in 1ll.111Y ,rudit" Ccfcplln'
ctlic.lcy 111 LRTI olllparable wHh ccti..zldII lle ,lItd
cfOta.XII1W [2,.31 Th,'rc!orr:, cetepllllc is JIl "tfewvc alter-
1l:It1Ve ro IllIrd-g"llel~1t1011ceph,losponns III clllplncal therapy
of febrile lll'utropel1la, prt'sulllpnve Ild cst:lulislwd 1I05Oeo-
nllal epllCl'mi,. III LR1'1. 11l comphc,lU:d UTls, Skill alld S (I-
ll. 'uc mfcetiol15. ,\OJ in I11t'lIil1glU$ [7,R].
)11 111<' ha)" of th" C onsldcrat!ol15. and of ur cxpenCll c, W ...
';Ill IIggeSl a h"dule (or cl11l'lncal I'hl: p of everc Illfect! n-
Our chol·e. \Vh... ,..,. that' 1< J high mcidence of teSN:;ml ~[r.um, I.'
a tllll(th-gell<:raoon cephalosponn plul all aI1uno~yco\lde, lor
the bctTer ellicacy of tounh-gellCr.1lJOn ccph.1.Io'I'Onll~ 'os
fl'nllr:llong and nonft'nnenong GraUl-nc!'-o;tOve melena. Mnno-
lhenpy IS pns ibl.... hut there 3n: a (ew pr 1It'ITlS, $IKh a~ pO<'<lblc
re i.ltall e to flu r qllillOIOllt~ ,HId epidelll10h gI l-ph3nl1.1("0('-
OIlOllllC problems (or carl'al elR'lIlS, M reover, r. r a afer usc of
fourrh-ltcncraool1 eph.llosponlt\. \ e preler to employ tltem 11\
aSSOClanOIl wnh an ,1JllIlloglyt'oSllle, 111 the trearment of C"'I:H'
Illfe 'uons, parocl.1L1r1y 111 c\lIldrCII nd 111 COlllprollUlt'd I'JO'·IIt'i.
Resistance problem
rl'~I>[aIlC" ((l .1IInblonn, nltcll dlll: ro rheir inal'propn,llc 11>",
CurrctH re>I,lall ·e~ IOvolve Illmt al1C1l11ori,· 'l;lSSe~ (' alll<- J),
R''''''OIKe 1> cllll''Wn~ III halh (;r.IJlI-rositive and ,,\111-
lleg:"IVl' 1l\ll·I'l.I0fl.\:oII11SIIL', b,15l'd un "~nOIL' I1lCCh::lIlL\1l1> (fabl,' -I),
I'rC\'I<lI.I\ expa,en '1' ~ul'b""'t'; that cllll'lncal the .11" f evcre
IIlf,'cuom -IlOlIld Ill' based Lm ,I cOlllbm;!!\( n ofhro,ld spectrum IJ-
bn:lIll> rlns ,1flllnogly,·o,tlk'\. or, nlllllothe '1')' wirh llUoroqlll-
11010111''', carbapclll'nl> ,)1' fourth-gelll: ,non ccphalo'l'orills [II,
In comblll.lltOIl r1wral'Y It I~ adVIsable to I'mploy broad-
~pectntnl cephal l~l'onm bc au,l' thell' ph~rntacoklll<'nc ::ICUV-
I~' 111 rhe re'pl , wry I(,IC[ i.~ upenol' to th,lt (' pelllciIlil15 and
thow of ,ll1\.lItogly (),.dc, kss ,mccpuble w cnzyme m CUV,I-
non (allllbcm).
TIll' lIS,' 'If thlr,l-gt'm' .Ii ,ll (.cph~lo>ponm ill the la. r 10
yca~ h,,' contnblltt'd tn the ~I'rc,ld , (' I:xtcndt'J-'I'c -trum ~-
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Interplay of different reSIstance
mechanisms
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